131 related articles for article (PubMed ID: 26876814)
1. Aldosterone and type 2 diabetes mellitus.
Zavatta G; Casadio E; Rinaldi E; Pagotto U; Pasquali R; Vicennati V
Horm Mol Biol Clin Investig; 2016 Apr; 26(1):53-9. PubMed ID: 26876814
[TBL] [Abstract][Full Text] [Related]
2. Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?
Widimský J; Strauch B; Sindelka G; Skrha J
Physiol Res; 2001; 50(6):603-7. PubMed ID: 11829322
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
[TBL] [Abstract][Full Text] [Related]
4. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
Ferrannini E; Seghieri G; Muscelli E
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S61-9. PubMed ID: 7700069
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
6. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
Jing F; Mogi M; Horiuchi M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
[TBL] [Abstract][Full Text] [Related]
7. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
[TBL] [Abstract][Full Text] [Related]
8. Links between aldosterone excess and metabolic complications: A comprehensive review.
Bothou C; Beuschlein F; Spyroglou A
Diabetes Metab; 2020 Feb; 46(1):1-7. PubMed ID: 30825519
[TBL] [Abstract][Full Text] [Related]
9. Renin angiotensin aldosterone system and glycemia in pregnancy.
Chen YP; Li J; Wang ZN; Reichetzeder C; Xu H; Gong J; Chen GJ; Pfab T; Xiao XM; Hocher B
Clin Lab; 2012; 58(5-6):527-33. PubMed ID: 22783584
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
11. Hypertension and diabetes: role of the renin-angiotensin system.
Jandeleit-Dahm K; Cooper ME
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
[TBL] [Abstract][Full Text] [Related]
12. Role of aldosterone and angiotensin II in insulin resistance: an update.
Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism and metabolic syndrome.
Fallo F; Pilon C; Urbanet R
Horm Metab Res; 2012 Mar; 44(3):208-14. PubMed ID: 22116746
[TBL] [Abstract][Full Text] [Related]
14. [Relations between blood insulin concentration, renin-angiotensin-aldosterone system and clinical picture of hypertension].
Didenko VA; Simonov DV
Ter Arkh; 1999; 71(1):26-31. PubMed ID: 10097296
[TBL] [Abstract][Full Text] [Related]
15. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
16. The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus.
Davies J; Struthers A
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):150-5. PubMed ID: 12563564
[TBL] [Abstract][Full Text] [Related]
17. Glucose Metabolism in Primary Aldosteronism.
Remde H; Hanslik G; Rayes N; Quinkler M
Horm Metab Res; 2015 Dec; 47(13):987-93. PubMed ID: 26667801
[TBL] [Abstract][Full Text] [Related]
18. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C
J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
[TBL] [Abstract][Full Text] [Related]
19. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
Egan BM; Stepniakowski K; Goodfriend TL
Am J Hypertens; 1994 Oct; 7(10 Pt 1):886-93. PubMed ID: 7826551
[TBL] [Abstract][Full Text] [Related]
20. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
